Average Co-Inventor Count = 10.94
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Compugen Ltd. Corporation (17 from 61 patents)
17 patents:
1. 9428586 - Heparanase splice variant
2. 8828940 - Method of treating an ischemia-reperfusion injury-related disorder by administering GPCR ligands
3. 8349801 - Peptide ligands for G-protein coupled receptors
4. 7939634 - Polynucleotides encoding polypeptides and methods using same
5. 7906635 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
6. 7884180 - Peptides which bind to G protein-coupled receptors
7. 7842459 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
8. 7758862 - Hepatocyte growth factor receptor splice variants and methods of using same
9. 7714100 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
10. 7678769 - Hepatocyte growth factor receptor splice variants and methods of using same
11. 7601692 - MCP-1 splice variants and methods of using same
12. 7569662 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
13. 7553948 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
14. 7528243 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
15. 7368548 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer